Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 54.7 USD -2.25% Market Closed
Market Cap: 6.4B USD
Have any thoughts about
Cytokinetics Inc?
Write Note

Cytokinetics Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cytokinetics Inc
Research & Development Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Cytokinetics Inc
NASDAQ:CYTK
Research & Development
-$330.8m
CAGR 3-Years
-31%
CAGR 5-Years
-29%
CAGR 10-Years
-21%
Abbvie Inc
NYSE:ABBV
Research & Development
-$7.9B
CAGR 3-Years
-4%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Gilead Sciences Inc
NASDAQ:GILD
Research & Development
-$5.5B
CAGR 3-Years
-4%
CAGR 5-Years
10%
CAGR 10-Years
-9%
Amgen Inc
NASDAQ:AMGN
Research & Development
-$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Research & Development
-$3.5B
CAGR 3-Years
-7%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Research & Development
-$4.9B
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
-15%

See Also

What is Cytokinetics Inc's Research & Development?
Research & Development
-330.8m USD

Based on the financial report for Sep 30, 2024, Cytokinetics Inc's Research & Development amounts to -330.8m USD.

What is Cytokinetics Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-21%

Over the last year, the Research & Development growth was -3%. The average annual Research & Development growth rates for Cytokinetics Inc have been -31% over the past three years , -29% over the past five years , and -21% over the past ten years .

Back to Top